Abstract
One third of pancreatic cancers (PC) are borderline-resectable (BL) or locally advanced (LA). Even in the absence of metastases, prognosis is poor. There is a lack of prospective data supporting the best approach for these tumors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
